Skip to main content
. 2021 Sep 17;297(4):101207. doi: 10.1016/j.jbc.2021.101207

Table 2.

Summary of IC50 calculations for SARS-CoV-2 sulfated glycan inhibitors

Sulfated glycan IC50 (mg/l)a 95% CI pb pc pd
UFH 0.2497 0.09372–6.248 - - -
PpFucCS 0.0279 0.008141–0.09018 0.0149 - -
IbFucCS 0.0217 0.006013–0.06791 0.0053 0.5840 -
IbSF 0.0196 0.005204–0.05298 0.0018 0.3999 0.9432

Abbreviation: 95% CI, 95% confidence limits.

a

IC50 values of anti-SARS-CoV-2 inhibitory activity of heparin and holothurian sulfated glycans were determined against HEK 293T cells infected with baculovirus pseudotyped with SARS-CoV-2 (Wuhan strain) wildtype S-protein with 95% confidence limits.

b

p-Values were determined by comparing the IC50 values of holothurian sulfated glycans with UFH using extra sum of squares F test.

c

p-Values were determined by comparing the IC50 values of holothurian sulfated glycans with PpFucCS.

d

p-Values were determined by comparing the IC50 values of holothurian sulfated glycans with IbFucCS.